Skip to main content
SpringerLink
Log in

Cervical Carcinoma Surveillance Counterpoint: USA

  • Chapter
  • First Online:
Patient Surveillance After Cancer Treatment

Part of the book series: Current Clinical Oncology ((CCO))

  • 139 Accesses

Abstract

The role of follow-up surveillance for patients treated for cervical cancer with curative intent has not been fully defined. The National Comprehensive Cancer Network (NCCN) practice guidelines for surveillance recommend office visits and Pap tests every 3 months the first year, every 4 months the second year, every 6 months the third year, then annually (Table 64.1) [1]. They also recommend performing a chest X-ray annually with other imaging studies ordered as clinically indicated. The American College of Obstetricians and Gynecologists (ACOG) notes that patients treated for cervical cancer should be monitored regularly with thrice-yearly follow-up examinations the first 2 years and twice yearly, subsequently to year 5, with Pap tests and chest X-rays annually [2]. These recommendations are based primarily on expert opinion and consensus. Although evidence-based criteria for screening strategies are lacking and strict screening strategies are not uniformly implemented, the approach reported by most authors broadly consists of examinations every 3 months the year following treatment, with increasing intervals between screening the subsequent years. Pap smears, chest X-rays, and ultrasounds are used with varying frequency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. NCCN Clinical Practice Guidelines in Oncology-Cervical Cancer (V.I.2009).

    Google Scholar 

  2. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35, May 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;78:79–91.

    Google Scholar 

  3. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam. 1968;65:281–393.

    PubMed  CAS  Google Scholar 

  4. Larson DM, Copeland LJ, Stringer CA, et al. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol. 1988;30:381–7.

    Article  PubMed  CAS  Google Scholar 

  5. Gerdin E, Cnattingius S, Johnson P, Pettersson B. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy. Gynecol Oncol. 1994;53:314–9.

    Article  PubMed  CAS  Google Scholar 

  6. Samlal RA, Van Der Velden J, Van Eerden T, et al. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8:78–84.

    Article  PubMed  Google Scholar 

  7. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535–40.

    Article  PubMed  CAS  Google Scholar 

  8. Ferrigno R, Campos de Oliveira Faria SL, Weltman E, et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys. 2003;55:695–706.

    Article  PubMed  Google Scholar 

  9. Hong JH, Tsai CS, Chang JT, et al. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:823–30.

    Article  PubMed  CAS  Google Scholar 

  10. Hong JH, Tsai CS, Lai CH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:249–57.

    Article  PubMed  Google Scholar 

  11. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–43.

    Article  PubMed  CAS  Google Scholar 

  12. Krebs HB, Helmkamp BF, Sevin BU, et al. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol. 1982;59:422–7.

    PubMed  CAS  Google Scholar 

  13. Larson DM, Copeland LJ, Malone Jr JM, et al. Diagnosis of recurrent cervical carcinoma after radical hysterectomy. Obstet Gynecol. 1988;71:6–9.

    PubMed  CAS  Google Scholar 

  14. Burke TW, Hoskins WJ, Heller PB, et al. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol. 1987;69:382–5.

    PubMed  CAS  Google Scholar 

  15. Look KY, Rocereto TF. Relapse patterns in FIGO stage IB carcinoma of the cervix. Gynecol Oncol. 1990;38:114–20.

    Article  PubMed  CAS  Google Scholar 

  16. Tinga DJ, Bouma J, Boonstra H, Aalders JG. Symptomatology, localization and treatment of recurrent cervical carcinoma. Int J Gynecol Cancer. 1992;2:179–88.

    Article  PubMed  Google Scholar 

  17. Fagundes H, Perez CA, Grigsby PW, Lockett MA. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1992;24:197–204.

    Article  PubMed  CAS  Google Scholar 

  18. Bodurka-Bevers D, Morris M, Eifel PJ, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000;78:187–93.

    Article  PubMed  CAS  Google Scholar 

  19. Duyn A, Van Eijkeren M, Kenter G, Zwinderman K, Ansink A. Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand. 2002;81:351–5.

    Article  PubMed  Google Scholar 

  20. Morice P, Deyrolle C, Rey A, et al. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. Ann Oncol. 2004;15:218–23.

    Article  PubMed  CAS  Google Scholar 

  21. Sartori E, Pasinetti B, Carrara L, Gambino A, Odicino F, Pecorelli S. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol. 2007;107:S241–7.

    Article  PubMed  CAS  Google Scholar 

  22. Zola P, Fuso L, Mazzola S, et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol. 2007;107:S150–4.

    Article  PubMed  CAS  Google Scholar 

  23. van Nagell Jr JR, Rayburn W, Donaldson ES, et al. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer. 1979;44:2354–61.

    Article  PubMed  Google Scholar 

  24. Friedlander M, Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist. 2002;7:342–7.

    PubMed  Google Scholar 

  25. Kew FM, Roberts AP, Cruickshank DJ. The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer. 2005;15:413–9.

    Article  PubMed  CAS  Google Scholar 

  26. Ansink A, de Barros Lopes A, Naik R, Monaghan JM. Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow up surveillance. Br J Obstet Gynaecol. 1996;103:1156–8.

    Article  PubMed  CAS  Google Scholar 

  27. Shield PW, Wright RG, Free K, Daunter B. The accuracy of cervicovaginal cytology in the detection of recurrent cervical carcinoma following radiotherapy. Gynecol Oncol. 1991;41:223–9.

    Article  PubMed  CAS  Google Scholar 

  28. Soisson AP, Geszler G, Soper JT, Berchuck A, Clarke-Pearson DL. A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. Obstet Gynecol. 1990;76:106–9.

    PubMed  CAS  Google Scholar 

  29. Owen P, Duncan ID. Is there any value in the long term follow up of women treated for endometrial cancer? Br J Obstet Gynaecol. 1996;103:710–3.

    Article  PubMed  CAS  Google Scholar 

  30. Barter JF, Soong SJ, Hatch KD, Orr JW, Shingleton HM. Diagnosis and treatment of pulmonary metastases from cervical carcinoma. Gynecol Oncol. 1990;38:347–51.

    Article  PubMed  CAS  Google Scholar 

  31. Boice Jr JD, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst. 1985;74:955–75.

    PubMed  Google Scholar 

  32. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99:1634–43.

    Article  PubMed  Google Scholar 

  33. Hemminki K, Dong C, Vaittinen P. Second primary cancer after in situ and invasive cervical cancer. Epidemiology. 2000;11:457–61.

    Article  PubMed  CAS  Google Scholar 

  34. Kleinerman RA, Boice Jr JD, Storm HH, et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer. 1995;76:442–52.

    Article  PubMed  CAS  Google Scholar 

  35. Fisher G, Harlow SD, Schottenfeld D. Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985-1992. Gynecol Oncol. 1997;64:213–23.

    Article  PubMed  CAS  Google Scholar 

  36. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol. 1992;136:54–8.

    PubMed  CAS  Google Scholar 

  37. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.

    Article  PubMed  CAS  Google Scholar 

  38. Allan JM, Travis LB. Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer. 2005;5:943–55.

    Article  PubMed  CAS  Google Scholar 

  39. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY, 14263, USA

    Joshua P. Kesterson M.D. & Shashikant Lele M.D.

Authors
  1. Joshua P. Kesterson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shashikant Lele M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shashikant Lele M.D. .

Editor information

Editors and Affiliations

  1. Department of Surgery, Saint Louis University, Vista Avenue 3635, St. Louis, 63110-0050, Missouri, USA

    Frank E. Johnson

  2. Fac. Medicine, Dept. Surgery II, Kyushu University, Fukuoka, 812-8582, Japan

    Yoshihiko Maehara

  3. BC Cancer Agency, West 10th Avenue 600, Vancouver, V5Z 4E6, British Columbia, Canada

    George P. Browman

  4. School of Medicine, Washington University, S. Euclid Ave. 660, St. Louis, 63110, Missouri, USA

    Julie A. Margenthaler

  5. St Helens Teaching Hospital, University of Liverpool, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

  6. Sydney Cancer Centre, Sydney Melanoma Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown, 2050, New South Wales, Australia

    John F. Thompson

  7. Saint Louis University Medical Center, Saint Louis, 63103, Missouri, USA

    David Y. Johnson

  8. Dana-Farber Cancer Institute, Harvard Medical School, Binney St. 44, Boston, 02115, Massachusetts, USA

    Craig C. Earle

  9. International Atlantic Economic Society, Peachtree Center 299, NEInternatio, Atlanta, 30303, Georgia, USA

    Katherine S. Virgo

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Humana Press

About this chapter

Cite this chapter

Kesterson, J.P., Lele, S. (2013). Cervical Carcinoma Surveillance Counterpoint: USA. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_64

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-969-7_64

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-968-0

  • Online ISBN: 978-1-60327-969-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation